MELONI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 8.130
AS - Asia 5.576
EU - Europa 5.000
SA - Sud America 723
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 181
OC - Oceania 7
Totale 19.823
Nazione #
US - Stati Uniti d'America 7.913
CN - Cina 2.585
SG - Singapore 1.307
IE - Irlanda 1.048
DE - Germania 645
HK - Hong Kong 589
FI - Finlandia 569
BR - Brasile 568
UA - Ucraina 559
RU - Federazione Russa 525
IT - Italia 510
VN - Vietnam 480
FR - Francia 307
SE - Svezia 287
GB - Regno Unito 258
IN - India 129
CA - Canada 117
ZA - Sudafrica 104
BD - Bangladesh 96
JP - Giappone 69
MX - Messico 58
IQ - Iraq 57
AR - Argentina 56
PL - Polonia 50
ES - Italia 41
TR - Turchia 40
BE - Belgio 33
NL - Olanda 32
ID - Indonesia 27
EC - Ecuador 26
AT - Austria 25
PK - Pakistan 25
CZ - Repubblica Ceca 24
SA - Arabia Saudita 20
UZ - Uzbekistan 20
MY - Malesia 19
CO - Colombia 18
CL - Cile 17
VE - Venezuela 17
PH - Filippine 15
LT - Lituania 13
MA - Marocco 13
PY - Paraguay 13
AZ - Azerbaigian 12
IR - Iran 12
AE - Emirati Arabi Uniti 11
KE - Kenya 10
TN - Tunisia 10
AL - Albania 9
CH - Svizzera 8
EG - Egitto 8
KZ - Kazakistan 8
PT - Portogallo 8
DZ - Algeria 7
EU - Europa 7
JM - Giamaica 7
LV - Lettonia 7
NP - Nepal 7
RO - Romania 7
MU - Mauritius 6
PA - Panama 6
RS - Serbia 6
AU - Australia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
GR - Grecia 5
AO - Angola 4
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
NI - Nicaragua 4
SN - Senegal 4
TH - Thailandia 4
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
KR - Corea 3
KW - Kuwait 3
MN - Mongolia 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DM - Dominica 2
EE - Estonia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
TG - Togo 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
Totale 19.599
Città #
Dublin 1.043
Chandler 974
Ashburn 789
San Jose 777
Singapore 732
Jacksonville 657
Dallas 617
Hong Kong 575
Nanjing 483
Beijing 479
Boardman 324
Council Bluffs 251
Helsinki 229
Munich 229
Los Angeles 224
Nanchang 178
New York 177
Princeton 177
Lauterbourg 170
Lawrence 168
Wilmington 157
Shenyang 150
Ho Chi Minh City 149
Hebei 142
Changsha 135
Jiaxing 126
Medford 126
Hanoi 113
Moscow 111
Ann Arbor 110
Milan 98
Johannesburg 92
Pavia 92
Shanghai 92
Tianjin 81
Buffalo 80
Hangzhou 77
Santa Clara 73
Turku 69
Redondo Beach 66
Tokyo 64
Orem 61
São Paulo 55
Seattle 48
Woodbridge 48
Warsaw 44
London 43
Verona 42
The Dalles 40
Toronto 40
Brooklyn 36
Montreal 36
Washington 34
Columbus 33
Brussels 31
Houston 30
Atlanta 28
Chicago 28
Norwalk 28
Chennai 27
Da Nang 26
Frankfurt am Main 26
Denver 25
Haiphong 25
Stockholm 25
Rio de Janeiro 24
San Francisco 24
Baghdad 22
Falkenstein 22
Zhengzhou 22
Boston 21
Kunming 21
Mexico City 20
Phoenix 20
Biên Hòa 18
Poplar 18
Vienna 18
Des Moines 17
Paris 17
Pune 17
Tashkent 17
Nuremberg 16
Piscataway 15
Manchester 14
Amsterdam 13
Belo Horizonte 13
Fairfield 13
Jinan 13
Guangzhou 12
Baku 11
Curitiba 11
Mumbai 11
Ninh Bình 11
Ottawa 11
Porto Alegre 11
Taizhou 11
Brno 10
Istanbul 10
Kuala Lumpur 10
Ningbo 10
Totale 12.859
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 268
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 178
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 178
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 169
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 167
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 166
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 165
A mid-term follow-up with a lung ultrasonographic score correlates with the severity of COVID-19 acute phase 163
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 160
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 159
Fotoaferesi extracorporea nel trattamento del rigetto polmonare cronico: risultati clinici ed immunologici preliminari di una piccola coorte di pazienti sottoposti a trapianto di polmone. 159
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 158
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 157
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 155
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 152
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 151
Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. 149
Specific Anti-CMV Reactivity in BAL: A Useful Tool 146
(1)H NMR To Evaluate the Metabolome of Bronchoalveolar Lavage Fluid (BALf) in Bronchiolitis Obliterans Syndrome (BOS): Toward the Development of a New Approach for Biomarker Identification. 146
Minute pulmonary meningothelial-like nodules in the transbronchial biopsy of a lung transplant recipient 144
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 143
Indoleamine 2,3-dioxygenase in lung allograft tolerance. 142
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 141
Broncho-alveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to the onset of bronchiolitis obliterans syndrome 140
Regulatory T cells in kidney transplant recipients. 140
Effetti clinici ed immunologici di un trattamento a lungo termine con azitromicina nella sindrome da bronchiolite obliterante dopo trapianto polmonare. 139
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients 139
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 138
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 138
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 135
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 135
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 135
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe 133
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 132
Aortic valve replacement performed twice through ministernotomy 15 years after lung transplantation. 131
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 131
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 130
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 130
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 130
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 130
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 129
Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T 127
Experience with Cylex Immune Cell Function Assay in Clinical Immune Monitoring of Lung Transplant Recipients 127
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 125
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 125
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 124
Incidence of de novo malignancies in lung transplant recipients in Italy: a sinle institution experience, 1991-2008. 123
An innovative cellular approach to BOS: targeted antibody-engineered gold nanoparticles and characterization of cells for new therapeutic treatment 123
Mid-term follow-up chest CT findings in recovered COVID-19 patients with residual symptoms 122
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 122
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 122
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane 121
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. 121
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 121
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients 119
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 119
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 118
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 118
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 118
Activity of Th1/Th2 lymphocytes in primary and HCV-related mesangiocapillary glomerulonephritis. 116
Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation 115
Cerebrospinal fluid ferritin in human disease. 115
Rischio di sviluppo di tumori de-novo dopo trapianto di polmone in Italia: esperienza dell'I.R.C.C.S. Policlinico "San Matteo" di Pavia, 1991-2008. 114
Organ Allocation Waiting Time During Extracorporeal Bridge to Lung Transplant Affects Outcomes 113
Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipiets 113
Persistent human cosavirus infection in lung transplant recipient, Italy. 112
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome. 112
Possible Disease Markers in BAL Fluid of BOS Patients 111
Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation 111
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 110
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo 110
Early Development of Metabolic Syndrome in Patients Subjected to Lung Transplantation 110
[Ca2+]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. 109
Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study 108
Urinary monocyte chemotactic peptide (U/MCP-1) and RANTES (U/RANTES) excretion in human lupus nephritis (SLE/N) 107
Valutazione longitudinale delle cellule treg cd4+cd25highc69- in una coorte di riceventi di trapianto polmonare (ltrs). Un'associazione con il rigetto cronico del trapianto. 107
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients 107
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 106
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop 106
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 105
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 105
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 105
Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles 105
Role of interleukin18 (IL-18) and interleukin 12 (IL-12) in human lupus nephritis (SLE-N) 101
Mechanisms of lung injury in cystic fibrosis. 101
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 101
Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study 101
Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus 101
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p 101
Cytokine profile of broncho-alveolar lavage in BOOP and UIP 100
Caratteristiche cliniche correlate con la diagnosi istologica della bronchiolite obliterante infiammatoria o fibrotica. 100
CCR4, CCR5, CCR6 expression on BAL lymphocytes and macrophages of patients with bronchiolitis obliterans syndrome 100
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation 100
SORVEGLIANZA DELLE MALATTIE BRONCOPOLMONARI CRONICO-OSTRUTTIVE NELLA POPOLAZIONE DI ROVESCALA (PAVIA) IN RELAZIONE ALL’ ESPOSIZIONE AL FUMO DI TABACCO 100
Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: A 10-year single-centre analysis 100
Urinary interleukin-18 (IL-18) and monocyte chemotactic peptide-1 (MCP-1) excretion in IGA Nephropathy (IgAN) 99
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 99
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 99
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 98
Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages 98
Totale 12.657
Categoria #
all - tutte 84.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022722 0 5 18 13 22 20 20 40 50 24 117 393
2022/20232.852 297 206 15 256 290 275 1 163 1.231 21 64 33
2023/20241.302 147 210 59 79 137 341 43 79 8 101 34 64
2024/20253.149 77 210 94 109 87 231 187 282 740 113 353 666
2025/20266.993 546 417 887 732 844 360 1.351 294 604 484 232 242
2026/2027383 163 220 0 0 0 0 0 0 0 0 0 0
Totale 19.823